STEM CELL THERAPY FOR BLOOD VESSEL DEGENERATION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090291061A1
SERIAL NO

12470438

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides means of treating degenerated blood vessels through administration of stem cells or activators of stem cells. In one particular embodiment vessel reactivity is increased through administration of stem cells or stem cell activating compounds. Other embodiments include “reconditioning” of vessels prone to aneurysms, repairing aneurysms of vessels, or acceleration of endothelialization after stent placement. Provided within the invention are methods of rejuvenating properties of said vessels associated with physiological health, examples of which include appropriate production of anti-coagulating/clotting factors, control of angiogenesis, and appropriate revascularization of injured tissue.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • Assignment data not available. Check PTO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ichim, Thomas E San Diego , US 27 214
Riordan, Neil H Chandler , US 35 208

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (2)
* 2007/0166,289 AUTOLOGOUS HUMAN DNA GRAFTING - ANTI- & REVERSE AGING PROCESS, METHOD 0 2006
* 2009/0123,433 Compositions Comprising Human Embryonic Stem Cells and their Derivatives, Methods of Use, and Methods of Preparation 10 2007
 
Medistem Labortories (1)
* 2008/0260,703 Treatment of Insulin Resistance and Diabetes 14 2008
 
MESOBLAST INTERNATIONAL SARL (1)
* 5733542 Enhancing bone marrow engraftment using MSCS 77 1995
 
UNIVERSITY OF IOWA RESEARCH FOUNDATION (1)
* 2005/0119,536 Diagnostics and therapeutics for arterial wall disruptive disorders 5 2004
 
NEWLENS, LLC (1)
* 2007/0178,071 Stem-cell, precursor cell, or target cell-based treatment of multiorgan failure and renal dysfunction 2 2004
 
MEDISTEM LABORATORIES, INC (1)
* 2008/0050,347 STEM CELL THERAPY FOR CARDIAC VALVULAR DYSFUNCTION 24 2007
 
Northern Therapeutics, Inc. (1)
* 2008/0050,349 CELL BASED THERAPY FOR THE PULMONARY SYSTEM 7 2007
 
MEDTRONIC VASCULAR, INC. (1)
* 7387645 Cellular therapy to heal vascular tissue 2 2003
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (1)
* 2010/0247,495 Treatment of Muscular Dystrophy 6 2010
 
Ludwick Hirszfeld Institute of Immunology and Experimental Therapy Polish Academy (1)
* 9631178 Human and murine stem-cell lines: models of endothelial cell precursors 0 2011
 
AUXOCELL LABORATORIES, INC. (6)
8893995 Systems and methods for processing cells 1 2013
D748462 Centrifuge clip 0 2014
8967512 Systems and methods for processing cells 0 2014
8967513 Systems and methods for processing cells 0 2014
9145544 Systems and methods for processing cells 0 2015
9663760 Systems and methods for processing cells 0 2015
 
ADVANCED NEUROREGENERATIVE THERAPIES, LLC (1)
* 2012/0093,764 TREATMENT OF DIABETES USING G-CSF AND HYPERBARIC OXYGEN 0 2010
 
ANTHROGENESIS CORPORATION (5)
8728805 Methods and compositions for treatment of bone defects with placental cell populations 0 2009
8367409 Amnion derived adherent cells 12 2009
8562973 Treatment of sarcoidosis using placental stem cells 4 2011
8969315 Enhancement of placental stem cell potency using modulatory RNA molecules 1 2011
9040035 Treatment of pain using placental stem cells 1 2012
 
ANTRHOGENESIS CORPORATION (1)
9198938 Amnion derived adherent cells 0 2012
* Cited By Examiner